OK-BIT
Scope
Date
~
-
Robotics
Koh Young gets OK from FDA for brain surgery robot
Koh Young Technology Inc., a South Korean developer of 3D optical inspection devices used in electronics manufacturing, said on Monday it got 501K...
Jan 21, 2025 (Gmt+09:00)
-
Bio & Pharma
JLK gets OK from FDA for ICH diagnosis solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, said on Monday it got 501K approval from the US Food and Drug Admin...
Jan 06, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Bio & Pharma
JLK gets FDA OK for prostate cancer diagnosis AI solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug ...
Jun 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets OK to sell Stelara biosimilar in Europe
South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...
Apr 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Gencurix gets FDA OK for breast cancer prognosis analysis device
South Korean biotech company Gencurix Inc. announced on Wednesday its subsidiary GenoBio has received approval from the US Food and Drug Admini...
Nov 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets FDA OK for its interchangeable biosimilar
Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official design...
Oct 25, 2023 (Gmt+09:00)
-
Regulations
Korea’s antitrust body grants conditional OK to Broadcom-VMware deal
South Korea’s antitrust regulator on Monday granted conditional approval for US smartphone components maker Broadcom Inc.’s proposed pur...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's GER drug gets product OK from Mexico
South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...
Oct 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Energy
US OKs Chinese-made solar modules using materials of S.Korea's OCI
The US has approved the import of Chinese-made solar panels using polysilicon from South Korea's green and energy company OCI Holdings Co.Pundits sa...
Sep 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to develop eye drops for diabetic retinopathy
South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...
Sep 15, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Boryung gets gov’t OK for diabetes drug Trubuddy
South Korea’s Boryung Corp. on Tuesday said it received approval from the Ministry of Food and Drug Safety for its new compound diabetes drug ...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets OK partial approval for phase 3 of biosimilar in Europe
South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma gets OK for phase 3 clinical trials of URC102 in Taiwan
South Korea's JW Pharmaceutical has won approval from Taiwan's Food and Drug Administration (TFDA) to conduct phase 3 clinical trials for its gout t...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...
Aug 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Ildong Bioscience gets US FDA OK for probiotic raw materials
South Korea's Ildong Bioscience on Thursday said two of its probiotic raw materials received the certification generally recognized as safe (GRAS) f...
Jul 14, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada
South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...
Jul 12, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
S.Korea's shipyards get OK from shipping companies to delay vessel delivery
South Korean shipbuilders are breathing a sigh of relief despite the postponed delivery of their container ships due to a chronic shortage of domest...
Jun 19, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HD Hyundai develops S.Korea's first offshore supply base for ammonia
HD Hyundai Co., the largest shipbuilding conglomerate in South Korea on Wednesday said it developed for the first time in the country a vessel for s...
Apr 19, 2023 (Gmt+09:00)
-
Banking & Finance
Korea Shinhan Financial taps banking unit head as group CEO
Shinhan Financial Group appointed the head of its flagship banking unit as the group’s next chief executive officer as the major South Korean ...
Dec 08, 2022 (Gmt+09:00)
-
Petrochemicals
S-Oil to OK $6 billion Shaheen project as Saudi prince heads to Seoul
S-Oil Corp., the South Korean unit of Saudi Arabian Oil Co., will approve the much-touted 8 trillion won ($6 billion) Shaheen project to expand its ...
Nov 14, 2022 (Gmt+09:00)
-
Cryptocurrencies
Hong Kong-based Crypto.com acquires South Korean exchange OK-BIT
Hong Kong-based Crypto.com announced Monday it finalized the acquisition of a 100% stake in South Korea’s cryptocurrency exchange operator OK-...
Aug 09, 2022 (Gmt+09:00)
-
Earnings
Chips, forex gains shore up Samsung's Q2 earnings
Samsung Electronics Co.’s second-quarter earnings remained steady compared to three months before, with robust memory chip sales for data cent...
Jul 28, 2022 (Gmt+09:00)
-
Shareholder activism
LG shareholders approve spin-off plan amid activist opposition
Shareholders of LG Corp., the holding company of South Korea’s fourth-largest conglomerate LG Group, on Friday gave the nod to the company's p...
Mar 26, 2021 (Gmt+09:00)
language
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand